4//SEC Filing
Laponis Adam 4
Accession 0001214659-25-015583
CIK 0001581280other
Filed
Oct 29, 8:00 PM ET
Accepted
Oct 30, 4:05 PM ET
Size
5.0 KB
Accession
0001214659-25-015583
Insider Transaction Report
Form 4
Laponis Adam
Chief Financial Officer
Transactions
- Award
Common Stock
2025-10-28+25,000→ 116,525 total
Footnotes (1)
- [F1]Represents Performance Stock Units for which target criteria was determined to have been met on October 28, 2025. 60% of the PSUs remain subject to time-based vesting and will vest on October 1, 2026, subject to continued service or acceleration of vesting as provided in the award agreement.
Documents
Issuer
Twist Bioscience Corp
CIK 0001581280
Entity typeother
Related Parties
1- filerCIK 0001827198
Filing Metadata
- Form type
- 4
- Filed
- Oct 29, 8:00 PM ET
- Accepted
- Oct 30, 4:05 PM ET
- Size
- 5.0 KB